Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 1
2021 1
2022 1
2023 5
2024 1
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial.
Hakeem A, Shah JA, Kumar R, Ali A, Lakho AA, Zeeshan H, Uddin MI, Khan K, Solangi B, Kumar M, Kumar M, Awan R, Ishaq H, Farooq F, Haq EU, Hameed A, Lehri WA, Zada S, Ali A, Raza A, Masood S, Humza A, Karim M; TADCLOT Investigators. Hakeem A, et al. Among authors: solangi b. J Am Coll Cardiol. 2025 Dec 9;86(23):2330-2345. doi: 10.1016/j.jacc.2025.08.041. Epub 2025 Aug 30. J Am Coll Cardiol. 2025. PMID: 40892606 Clinical Trial.
Rationale and design of the TADCLOT trial: A double blind randomized controlled trial comparing twice a day clopidogrel vs ticagrelor in reducing major cardiac events in patients with acute STEMI undergoing primary percutaneous coronary intervention.
Hakeem A, Ali Shah J, Kumar R, Khan K, Zeeshan H, Lakho AA, Ali A, Uddin MI, Solangi B, Kumar M, Kumar M, Awan R, Dilawar F, Ishaq H, Farooq F, Ul Haq E, Hameed A, Lehri WA, Zada S, Raza A, Masood S, Humza A, Karim M. Hakeem A, et al. Among authors: solangi b. Am Heart J. 2025 Sep;287:141-150. doi: 10.1016/j.ahj.2025.03.021. Epub 2025 Apr 12. Am Heart J. 2025. PMID: 40228593
One-year major adverse cardiovascular events among same-day discharged patients after primary percutaneous coronary intervention at a tertiary care cardiac centre in Karachi, Pakistan: a prospective observational study.
Shah JA, Kumar R, Solangi BA, Khan KA, Ahmed T, Khowaja S, Ali G, Zehra M, Sial JA, Karim M, Saghir T, Qamar N. Shah JA, et al. Among authors: solangi ba. BMJ Open. 2023 Apr 10;13(4):e067971. doi: 10.1136/bmjopen-2022-067971. BMJ Open. 2023. PMID: 37037620 Free PMC article.
Age and gender-based categorization of very premature, premature, and non-premature acute myocardial infarction: A comparison of clinical and angiographic profile and in-hospital outcomes.
Kumar R, Shaikh AH, Kumar A, Solangi BA, Naseer AB, Awan R, Chachar K, Talpur MFH, Saghir T, Sial JA, Qamar N, Karim M, Hakeem A. Kumar R, et al. Among authors: solangi ba. Int J Cardiol. 2023 Nov 15;391:131292. doi: 10.1016/j.ijcard.2023.131292. Epub 2023 Aug 23. Int J Cardiol. 2023. PMID: 37625483
12 results